Hypertension – The Heart in the Time of COVID-19

Do hypertension patients have high risk for COVID-19 ?

by:Eduardo Chuquiure-Valenzuela Recent studies about COVID-19 patients have reported that hypertension is associated with higher in-hospital complications and mortality. Also, worse results in angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARBs) were hypothesized. There was uncertainty about initial clinical studies solidity. Most of cardiologic societies around the world, advise to continue ACEI andContinue reading “Do hypertension patients have high risk for COVID-19 ?”

Association of renin-angiotensin system inhibitors with severity and outcomes of COVID-19 infection in hospitalized patients with hypertension

byLucrecia M. Burgos Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are not associated with severity and outcomes of coronavirus disease 2019 (COVID-19) infection in hospitalized patients with hypertension in Wuhan, China according to a recent study in JAMA Cardiology1. In this retrospective single-centre analysis, the authors analysed hospitalized patients with COVID-19 at the Central HospitalContinue reading “Association of renin-angiotensin system inhibitors with severity and outcomes of COVID-19 infection in hospitalized patients with hypertension”